Sure looking to me that we are at a point of a dependable bottom in the share price...if it can hold. It's hard to imagine anyone selling right now with CD12 coming rather soon (days? 2 weeks at MOST!), but each investor has their own reasons and needs. I'm certainly frustrated with Nader AND the BOD, but here we are. We've got some rookies and they are learning on the job. I agree with several that CD12 results are THE BIG item right now, and it would appear that the death # quoted by Nader suggests a great result for Leronlimab. We will see shortly.
To The Moon Alice